Rockwell Medical announced that its international partner, Drogsan Pharmaceuticals, submitted a Marketing Authorization application and GMP application for Triferic AVNU to the Turkish Medicines and Medical Devices Agency, for which Drogsan received priority status and high priority status, respectively.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on RMTI: